Table of Contents 1 Companion Diagnostic Tests in Oncology Market Overview 1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology 1.2 Classification of Companion Diagnostic Tests in Oncology by Types 1.2.1 Global Companion Diagnostic Tests in Oncology Revenue Comparison by Types (2017-2023) 1.2.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017 1.2.3 Protein Detection 1.2.4 DNA Detection 1.3 Global Companion Diagnostic Tests in Oncology Market by Application 1.3.1 Global Companion Diagnostic Tests in Oncology Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Pharmaceutical & Biotechnology Companies 1.3.3 Medical Device Companies 1.3.4 Research Institutes 1.4 Global Companion Diagnostic Tests in Oncology Market by Regions 1.4.1 Global Companion Diagnostic Tests in Oncology Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023) 1.5 Global Market Size of Companion Diagnostic Tests in Oncology (2013-2023) 2 Manufacturers Profiles 2.1 Abbott 2.1.1 Business Overview 2.1.2 Companion Diagnostic Tests in Oncology Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.2 Roche 2.2.1 Business Overview 2.2.2 Companion Diagnostic Tests in Oncology Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.3 Genomic Health 2.3.1 Business Overview 2.3.2 Companion Diagnostic Tests in Oncology Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.4 QIAGEN 2.4.1 Business Overview 2.4.2 Companion Diagnostic Tests in Oncology Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.5 Agilent 2.5.1 Business Overview 2.5.2 Companion Diagnostic Tests in Oncology Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.6 Agendia 2.6.1 Business Overview 2.6.2 Companion Diagnostic Tests in Oncology Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.7 BioMerieux 2.7.1 Business Overview 2.7.2 Companion Diagnostic Tests in Oncology Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.8 Illumina 2.8.1 Business Overview 2.8.2 Companion Diagnostic Tests in Oncology Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.9 Siemens Healthcare 2.9.1 Business Overview 2.9.2 Companion Diagnostic Tests in Oncology Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 2.10 Thermo Fisher 2.10.1 Business Overview 2.10.2 Companion Diagnostic Tests in Oncology Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) 3 Global Companion Diagnostic Tests in Oncology Market Competition, by Players 3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Companion Diagnostic Tests in Oncology Players Market Share 3.2.2 Top 10 Companion Diagnostic Tests in Oncology Players Market Share 3.3 Market Competition Trend 4 Global Companion Diagnostic Tests in Oncology Market Size by Regions 4.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Regions 4.2 North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 4.3 Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 4.5 South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 5 North America Companion Diagnostic Tests in Oncology Revenue by Countries 5.1 North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018) 5.2 USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 5.3 Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 5.4 Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 6 Europe Companion Diagnostic Tests in Oncology Revenue by Countries 6.1 Europe Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018) 6.2 Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 6.3 UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 6.4 France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 6.5 Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 6.6 Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries 7.1 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018) 7.2 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 7.3 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 7.4 Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 7.5 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 8 South America Companion Diagnostic Tests in Oncology Revenue by Countries 8.1 South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018) 8.2 Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 8.3 Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 8.4 Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Companion Diagnostic Tests in Oncology by Countries 9.1 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018) 9.2 Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 9.3 UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 9.4 Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 9.5 Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 9.6 South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) 10 Global Companion Diagnostic Tests in Oncology Market Segment by Type 10.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2013-2018) 10.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2018-2023) 10.3 Protein Detection Revenue Growth Rate (2013-2023) 10.4 DNA Detection Revenue Growth Rate (2013-2023) 11 Global Companion Diagnostic Tests in Oncology Market Segment by Application 11.1 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2013-2018) 11.2 Companion Diagnostic Tests in Oncology Market Forecast by Application (2018-2023) 11.3 Pharmaceutical & Biotechnology Companies Revenue Growth (2013-2018) 11.4 Medical Device Companies Revenue Growth (2013-2018) 11.5 Research Institutes Revenue Growth (2013-2018) 12 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023) 12.1 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023) 12.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Regions (2018-2023) 12.3 North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) 12.4 Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) 12.6 South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Companion Diagnostic Tests in Oncology Picture Table Product Specifications of Companion Diagnostic Tests in Oncology Table Global Companion Diagnostic Tests in Oncology and Revenue (Million USD) Market Split by Product Type Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017 Figure Protein Detection Picture Figure DNA Detection Picture Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Application (2013-2023) Figure Companion Diagnostic Tests in Oncology Revenue Market Share by Applications in 2017 Figure Pharmaceutical & Biotechnology Companies Picture Figure Medical Device Companies Picture Figure Research Institutes Picture Table Global Market Companion Diagnostic Tests in Oncology Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023) Table Abbott Basic Information, Manufacturing Base and Competitors Table Abbott Companion Diagnostic Tests in Oncology Type and Applications Table Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Companion Diagnostic Tests in Oncology Type and Applications Table Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Genomic Health Basic Information, Manufacturing Base and Competitors Table Genomic Health Companion Diagnostic Tests in Oncology Type and Applications Table Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table QIAGEN Basic Information, Manufacturing Base and Competitors Table QIAGEN Companion Diagnostic Tests in Oncology Type and Applications Table QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Agilent Basic Information, Manufacturing Base and Competitors Table Agilent Companion Diagnostic Tests in Oncology Type and Applications Table Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Agendia Basic Information, Manufacturing Base and Competitors Table Agendia Companion Diagnostic Tests in Oncology Type and Applications Table Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table BioMerieux Basic Information, Manufacturing Base and Competitors Table BioMerieux Companion Diagnostic Tests in Oncology Type and Applications Table BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Illumina Basic Information, Manufacturing Base and Competitors Table Illumina Companion Diagnostic Tests in Oncology Type and Applications Table Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors Table Siemens Healthcare Companion Diagnostic Tests in Oncology Type and Applications Table Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Thermo Fisher Basic Information, Manufacturing Base and Competitors Table Thermo Fisher Companion Diagnostic Tests in Oncology Type and Applications Table Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017) Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Players (2013-2018) Table Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2016 Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2017 Figure Global Top 5 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017 Figure Global Top 10 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017 Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Regions (2013-2018) Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions in 2017 Figure North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Table North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018) Table North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017 Figure USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Table Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018) Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017 Figure Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Table Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017 Figure China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Table South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018) Table South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017 Figure Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017 Figure Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Figure South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018) Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Type (2013-2018) Table Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type in 2017 Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2018-2023) Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2018-2023) Figure Global Protein Detection Revenue Growth Rate (2013-2018) Figure Global DNA Detection Revenue Growth Rate (2013-2018) Table Global Companion Diagnostic Tests in Oncology Revenue by Application (2013-2018) Table Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application in 2017 Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2018-2023) Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2018-2023) Figure Global Pharmaceutical & Biotechnology Companies Revenue Growth Rate (2013-2018) Figure Global Medical Device Companies Revenue Growth Rate (2013-2018) Figure Global Research Institutes Revenue Growth Rate (2013-2018) Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share Forecast by Regions (2018-2023) Figure North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) Figure South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023) Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Abbott Roche Genomic Health QIAGEN Agilent Agendia BioMerieux Illumina Siemens Healthcare Thermo Fisher